Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly for targeting tyrosine kinases involved in cancer cell signaling. Shows potential in developing treatments for solid tumors and hematological malignancies due to its ability to modulate cell proliferation and apoptosis pathways. Also explored for anti-inflammatory applications through selective enzyme inhibition. Commonly modified in structure-activity relationship (SAR) studies to enhance potency, selectivity, and bioavailability in drug candidates.